Taken these data with previous findings that both GPC3 and FAT1 were able to modulate the activity of YAP, the downstream effector of Hippo pathway35,61, it would be reasonable to postulate that GPC3 and FAT1 might function as complex in promoting HCC cell migration. The gene discussed is FAT1; the disease is hepatocellular carcinoma.